Analysed PROPANC BIOPHARMA INC (PPCB:NASDAQ) News Sources
Propanc Biopharma Implements Reverse Stock Split to Support Continued Nasdaq Listing and Growth Plans
14-05-2026
yahoo.com
Propanc Biopharma Provides Corporate Update and Reports Third Quarter 2025/26 Results
15-05-2026
yahoo.com
Propanc Biopharma Engages European CDMO for GMP Production of PRP for Phase 1b, FIH Study in 30 – 40 Advanced Cancer Patients
19-05-2026
yahoo.com
Propanc Biopharma’s CEO Forecasts New Medical Breakthroughs in the Fight Against Pancreatic Cancer Over the Next Decade
20-05-2026
yahoo.com
Propanc Biopharma’s CEO Attends Keynote Address, “Rejuvenation and Health: Science for an Ageing Society,” at the University of Granada, Spain
02-06-2026
yahoo.com
PPCB Stock Surges Over 200% Just Days After Implementing Reverse Share Split – What’s Driving Today’s Smashing Rally?
11-06-2026
stocktwits.com
Propanc Biopharma’s CEO Tours European CDMO & Plans for GMP Production of PRP for Phase 1b, FIH Study
16-06-2026
yahoo.com
What is the current price of PROPANC BIOPHARMA INC (PPCB:NASDAQ)?
The current price of PROPANC BIOPHARMA INC (PPCB:NASDAQ) is $1.61.
PROPANC BIOPHARMA INC (PPCB:NASDAQ) absolute price change since previous trading day?
The absolute price change of PROPANC BIOPHARMA INC (PPCB:NASDAQ) since the previous trading day is $-0.17.
PROPANC BIOPHARMA INC (PPCB:NASDAQ) percentage price change since previous trading day?
The percentage price change of PROPANC BIOPHARMA INC (PPCB:NASDAQ) since the previous trading day is -9.5506%.
What is the most recent average sentiment score for PROPANC BIOPHARMA INC (PPCB:NASDAQ)?
The most recent average sentiment score for PROPANC BIOPHARMA INC (PPCB:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for PROPANC BIOPHARMA INC (PPCB:NASDAQ)?
The most recent sentiment for PROPANC BIOPHARMA INC (PPCB:NASDAQ) is .
SEC-8K** Filing Available For PROPANC BIOPHARMA INC (PPCB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.